Filtros de búsqueda

Lista de obras de Eva Hoster

A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma

artículo científico publicado en 2008

Acute myeloid leukemia with biallelic CEBPA gene mutations and normal karyotype represents a distinct genetic entity associated with a favorable clinical outcome

artículo científico

Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymp

artículo científico publicado en 2016

Age-dependent frequencies of NPM1 mutations and FLT3-ITD in patients with normal karyotype AML (NK-AML).

artículo científico publicado en 2011

Autologous Stem Cell Transplantation for Patients with Early Progression of Follicular Lymphoma: A Follow-Up Study of 2 Randomized Trials from the German Low Grade Lymphoma Study Group

artículo científico publicado en 2018

B-cell receptor-driven MALT1 activity regulates MYC signaling in mantle cell lymphoma.

artículo científico publicado en 2016

Booster vaccination in the elderly: their success depends on the vaccine type applied earlier in life as well as on pre-vaccination antibody titers

artículo científico publicado en 2006

Clinical, pathological and genetic features of follicular lymphoma grade 3A: a joint analysis of the German low-grade and high-grade lymphoma study groups GLSG and DSHNHL.

artículo científico publicado en 2016

Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle c

artículo científico publicado en 2006

Combined molecular and clinical prognostic index for relapse and survival in cytogenetically normal acute myeloid leukemia

artículo científico publicado en 2014

Comparison of ABR and ASSR using NB-chirp-stimuli in children with severe and profound hearing loss

scientific article published on 07 January 2020

Confirmation of the mantle-cell lymphoma International Prognostic Index in randomized trials of the European Mantle-Cell Lymphoma Network

artículo científico publicado en 2014

Coronary dilatation after heart transplantation.

artículo científico publicado en 2011

Current therapeutic strategies for mantle cell lymphoma

artículo científico publicado en 2016

Current treatment strategies for follicular lymphoma

artículo científico publicado en 2016

Diagnostic and ethical challenges in disorders of consciousness and locked-in syndrome: a survey of German neurologists

artículo científico publicado en 2012

Early assessment of minimal residual disease in AML by flow cytometry during aplasia identifies patients at increased risk of relapse.

artículo científico publicado en 2014

Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the Eur

artículo científico publicado en 2004

Effects of fish-oil and folate supplementation of pregnant women on maternal and fetal plasma concentrations of docosahexaenoic acid and eicosapentaenoic acid: a European randomized multicenter trial

artículo científico publicado en 2007

Evaluating upfront high-dose consolidation after R-CHOP for follicular lymphoma by clinical and genetic risk models

scientific article published on 01 September 2020

Expression of TP53 is associated with the outcome of MCL independent of MIPI and Ki-67 in trials of the European MCL Network.

artículo científico publicado en 2017

FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab and chemotherapy.

artículo científico publicado en 2017

Five-gene model to predict survival in mantle-cell lymphoma using frozen or formalin-fixed, paraffin-embedded tissue

artículo científico publicado en 2008

Follicular dendritic cells in follicular lymphoma and types of non-Hodgkin lymphoma show reduced expression of CD23, CD35 and CD54 but no association with clinical outcome.

artículo científico publicado en 2011

GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia

artículo científico

Genetic heterogeneity of cytogenetically normal AML with mutations of

artículo científico publicado en 2018

Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV

High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma

artículo científico publicado en 2015

Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: res

artículo científico publicado en 2005

Immunomodulatory effects of aerobic training in obesity

artículo científico publicado en 2011

Immunoregulatory effects of the flavonol quercetin in vitro and in vivo.

artículo científico publicado en 2010

Impact of age on clinical risk scores in follicular lymphoma

artículo científico publicado en 2019

Impact of age on genetics and treatment efficacy in follicular lymphoma

artículo científico publicado en 2018

Impact of polyphenols on physiological stress and cardiac burden in marathon runners - results from a substudy of the BeMaGIC study.

artículo científico publicado en 2017

Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma

artículo científico publicado en 2008

Influence of polyphenol-rich diet on exercise-induced immunomodulation in male endurance athletes.

artículo científico publicado en 2017

Initial chemotherapy with mitoxantrone, chlorambucil, prednisone impairs the collection of stem cells in patients with indolent lymphomas--results of a randomized comparison by the German Low-Grade Lymphoma Study Group

artículo científico publicado en 2006

Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry

artículo científico publicado en 2015

Ki-67 as a prognostic marker in mantle cell lymphoma-consensus guidelines of the pathology panel of the European MCL Network

artículo científico publicado en 2009

Ki-67 predicts outcome in advanced-stage mantle cell lymphoma patients treated with anti-CD20 immunochemotherapy: results from randomized trials of the European MCL Network and the German Low Grade Lymphoma Study Group

artículo científico publicado en 2007

Localized- and advanced-stage follicular lymphomas differ in their gene expression profiles

artículo científico publicado en 2020

Long-term clinical and molecular remissions in patients with mantle cell lymphoma following high-dose therapy and autologous stem cell transplantation

artículo científico publicado en 2013

Long-term follow-up of cytogenetically normal CEBPA-mutated AML

artículo científico publicado en 2014

MRD response in relapsed/refractory FL after obinutuzumab plus bendamustine or bendamustine alone in the GADOLIN trial

scientific article published on 28 August 2019

MicroRNAs as Biomarkers for Acute Atrial Remodeling in Marathon Runners (The miRathon Study--A Sub-Study of the Munich Marathon Study).

artículo científico publicado en 2016

Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations.

artículo científico publicado en 2008

Minimal residual disease in mantle cell lymphoma: insights into biology and impact on treatment.

artículo científico publicado en 2016

Minimal residual disease monitoring by 8-color flow cytometry in mantle cell lymphoma: an EU-MCL and LYSA study

artículo científico publicado en 2015

Modulation of dendritic cells and toll-like receptors by marathon running.

artículo científico publicado en 2011

Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study

artículo científico publicado en 2009

Molecular response assessment by quantitative real-time polymerase chain reaction after induction therapy in NPM1-mutated patients identifies those at high risk of relapse

artículo científico publicado en 2014

Monoallelic CEBPA mutations in normal karyotype acute myeloid leukemia: independent favorable prognostic factor within NPM1 mutated patients ⬇️

artículo científico publicado el 24 de febrero de 2012

NPM1 but not FLT3-ITD mutations predict early blast cell clearance and CR rate in patients with normal karyotype AML (NK-AML) or high-risk myelodysplastic syndrome (MDS).

artículo científico publicado en 2009

Prognostic Relevance of Clinical Risk Factors in Mantle Cell Lymphoma ⬇️

artículo científico publicado el 1 de julio de 2011

Prognostic Significance of MYC Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium

scientific article published on 09 September 2019

Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network

artículo científico publicado en 2016

Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker Consortium.

artículo científico publicado en 2017

Reply to the letter to the editor 'the clinical dilemma of grade 3 follicular lymphoma' by Sorigue et al.

artículo científico publicado en 2016

Reproducibility of histologic prognostic parameters for mantle cell lymphoma: cytology, Ki67, p53 and SOX11

scientific article published on 23 January 2020

Rituximab With Involved Field Irradiation for Early-stage Nodal Follicular Lymphoma: Results of the MIR Study

artículo científico publicado en 2018

Similar clinical features in follicular lymphomas with and without breaks in the BCL2 locus.

artículo científico publicado en 2015

Speech Production Quality of Cochlear Implant Users with Respect to Duration and Onset of Hearing Loss.

artículo científico publicado en 2017

Strong overexpression of CXCR3 axis components in childhood inflammatory bowel disease

scientific article published on 01 November 2010

The FLIPI nowadays: validation and modification

artículo científico publicado en 2018

The FLT3ITD mRNA level has a high prognostic impact in NPM1 mutated, but not in NPM1 unmutated, AML with a normal karyotype

artículo científico publicado en 2012

The Follicular Lymphoma International Prognostic Index (FLIPI) separates high-risk from intermediate- or low-risk patients with advanced-stage follicular lymphoma treated front-line with rituximab and the combination of cyclophosphamide, doxorubicin

artículo científico publicado en 2006

The G protein-coupled estrogen receptor 1 (GPER-1) contributes to the proliferation and survival of mantle cell lymphoma cells

artículo científico publicado en 2015

The addition of rituximab to front-line therapy with CHOP (R-CHOP) results in a higher response rate and longer time to treatment failure in patients with lymphoplasmacytic lymphoma: results of a randomized trial of the German Low-Grade Lymphoma Stu

artículo científico publicado en 2008

The composition of the microenvironment in follicular lymphoma is associated with the stage of the disease

artículo científico publicado en 2012

The homeobox gene CDX2 is aberrantly expressed and associated with an inferior prognosis in patients with acute lymphoblastic leukemia

artículo científico publicado en 2009

The impact of SAMHD1 expression and mutation status in mantle cell lymphoma: An analysis of the MCL Younger and Elderly trial

artículo científico publicado en 2020

The role of relatives in decisions concerning life-prolonging treatment in patients with end-stage malignant disorders: informants, advocates or surrogate decision-makers?

artículo científico publicado en 2011

Thirty-Month Complete Response as a Surrogate End Point in First-Line Follicular Lymphoma Therapy: An Individual Patient-Level Analysis of Multiple Randomized Trials

artículo científico publicado en 2016

Time to Diagnosis in Cushing's Syndrome: A Meta-Analysis Based on 5367 Patients

artículo científico publicado en 2020

Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death

artículo científico publicado en 2018

Total body irradiation after high-dose cytarabine in mantle cell lymphoma: a comparison of Nordic MCL2, HOVON-45, and European MCL Younger trials.

artículo científico publicado en 2015

Treatment of Older Patients With Mantle Cell Lymphoma (MCL): Long-Term Follow-Up of the Randomized European MCL Elderly Trial

scientific article published on 05 December 2019

Treatment of older patients with mantle-cell lymphoma.

artículo científico publicado en 2012

Tumor sclerosis but not cell proliferation or malignancy grade is a prognostic marker in advanced-stage follicular lymphoma: the German Low Grade Lymphoma Study Group

artículo científico publicado en 2007

Update on the molecular pathogenesis and clinical treatment of Mantle Cell Lymphoma (MCL): minutes of the 9th European MCL Network conference.

artículo científico publicado en 2010

Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 10th annual conference of the European Mantle Cell Lymphoma Network

artículo científico

Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 11th annual conference of the European Mantle Cell Lymphoma Network

artículo científico publicado en 2012

Validation of the MCL35 gene expression proliferation assay in randomized trials of the European Mantle Cell Lymphoma Network

article

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda